Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Biologics Monoclonal Antibodies Drug market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Biologics Monoclonal Antibodies Drug Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Biologics Monoclonal Antibodies Drug Market by Type [Analysis by Value from 2020 to ]:
- Humanized
- Murine
- Chimeric
- Recombinant
Biologics Monoclonal Antibodies Drug Market by Application [Analysis by Value from 2020 to ]:
- Oncology
- Autoimmune Disorders
- Inflammatory Diseases
- Infectious Diseases
Key Players in the Biologics Monoclonal Antibodies Drug Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- Bristol-Myers Squibb
- GSK
- Merck
- Amgen
- Takeda
Biologics Monoclonal Antibodies Drug Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Biologics Monoclonal Antibodies Drug Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Biologics Monoclonal Antibodies Drug Market Size & Demand Forecast ()
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Biologics Monoclonal Antibodies Drug Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Biologics Monoclonal Antibodies Drug Segmentation & Growth Forecasts
The study systematically breaks down the Global Biologics Monoclonal Antibodies Drug Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Biologics Monoclonal Antibodies Drug Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Biologics Monoclonal Antibodies Drug market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Product Overview and Scope of Biologics Monoclonal Antibodies Drug
1.2 Global Biologics Monoclonal Antibodies Drug Market Size and Forecast
1.3 China Biologics Monoclonal Antibodies Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Biologics Monoclonal Antibodies Drug Share in Global Market, 2018-2029
1.4.2 Biologics Monoclonal Antibodies Drug Market Size: China VS Global, 2018-2029
1.5 Biologics Monoclonal Antibodies Drug Market Dynamics
1.5.1 Biologics Monoclonal Antibodies Drug Market Drivers
1.5.2 Biologics Monoclonal Antibodies Drug Market Restraints
1.5.3 Biologics Monoclonal Antibodies Drug Industry Trends
1.5.4 Biologics Monoclonal Antibodies Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Biologics Monoclonal Antibodies Drug Revenue by Company (2018-2023)
2.2 Global Biologics Monoclonal Antibodies Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Biologics Monoclonal Antibodies Drug Concentration Ratio
2.4 Global Biologics Monoclonal Antibodies Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Biologics Monoclonal Antibodies Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Biologics Monoclonal Antibodies Drug Revenue by Company (2018-2023)
3.2 China Biologics Monoclonal Antibodies Drug Biologics Monoclonal Antibodies Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Biologics Monoclonal Antibodies Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Biologics Monoclonal Antibodies Drug Industry Chain
4.2 Biologics Monoclonal Antibodies Drug Upstream Analysis
4.3 Biologics Monoclonal Antibodies Drug Midstream Analysis
4.4 Biologics Monoclonal Antibodies Drug Downstream Analysis
5 Sights by Type
5.1 Biologics Monoclonal Antibodies Drug Classification
5.1.1 Infliximab
5.1.2 Rituximab
5.1.3 Trastuzumab
5.1.4 Adalimumab
5.1.5 Other
5.2 By Type, Global Biologics Monoclonal Antibodies Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Biologics Monoclonal Antibodies Drug Revenue, 2018-2029
6 Sights by Application
6.1 Biologics Monoclonal Antibodies Drug Segment by Application
6.1.1 Cancer
6.1.2 Autoimmune Disease
6.1.3 Other
6.2 By Application, Global Biologics Monoclonal Antibodies Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Biologics Monoclonal Antibodies Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Biologics Monoclonal Antibodies Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Biologics Monoclonal Antibodies Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Biologics Monoclonal Antibodies Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Biologics Monoclonal Antibodies Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Biologics Monoclonal Antibodies Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biologics Monoclonal Antibodies Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Biologics Monoclonal Antibodies Drug Market Size Market Share
7.6 South America
7.6.1 South America Biologics Monoclonal Antibodies Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Biologics Monoclonal Antibodies Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Biologics Monoclonal Antibodies Drug Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.4.2 By Company, Europe Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.5.2 By Company, China Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.6.2 By Company, Japan Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.9.2 By Company, India Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Biologics Monoclonal Antibodies Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.1.4 Roche Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.1.5 Roche Recent Developments
9.2 Amgen
9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.2.2 Amgen Company Profile and Main Business
9.2.3 Amgen Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.2.4 Amgen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.2.5 Amgen Recent Developments
9.3 AbbVie
9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.3.2 AbbVie Company Profile and Main Business
9.3.3 AbbVie Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.3.4 AbbVie Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.3.5 AbbVie Recent Developments
9.4 Sanofi
9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.4.2 Sanofi Company Profile and Main Business
9.4.3 Sanofi Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.4.4 Sanofi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.4.5 Sanofi Recent Developments
9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.5.2 Johnson & Johnson Company Profile and Main Business
9.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.5.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.5.5 Johnson & Johnson Recent Developments
9.6 Pfizer
9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.6.2 Pfizer Company Profile and Main Business
9.6.3 Pfizer Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.6.4 Pfizer Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.6.5 Pfizer Recent Developments
9.7 Eli Lilly
9.7.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.7.2 Eli Lilly Company Profile and Main Business
9.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.7.4 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.7.5 Eli Lilly Recent Developments
9.8 Novartis
9.8.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.8.2 Novartis Company Profile and Main Business
9.8.3 Novartis Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.8.4 Novartis Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.8.5 Novartis Recent Developments
9.9 Merck
9.9.1 Merck Company Information, Head Office, Market Area and Industry Position
9.9.2 Merck Company Profile and Main Business
9.9.3 Merck Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.9.4 Merck Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.9.5 Merck Recent Developments
9.10 Biogen
9.10.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.10.2 Biogen Company Profile and Main Business
9.10.3 Biogen Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.10.4 Biogen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.10.5 Biogen Recent Developments
9.11 Sobi
9.11.1 Sobi Company Information, Head Office, Market Area and Industry Position
9.11.2 Sobi Company Profile and Main Business
9.11.3 Sobi Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.11.4 Sobi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.11.5 Sobi Recent Developments
9.12 Innovent Biologics
9.12.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.12.2 Innovent Biologics Company Profile and Main Business
9.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Models, Specifications and Application
9.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
9.12.5 Innovent Biologics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Biologics Monoclonal Antibodies Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Biologics Monoclonal Antibodies Drug Market Restraints
Table 3. Biologics Monoclonal Antibodies Drug Market Trends
Table 4. Biologics Monoclonal Antibodies Drug Industry Policy
Table 5. Global Biologics Monoclonal Antibodies Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Biologics Monoclonal Antibodies Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Biologics Monoclonal Antibodies Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Biologics Monoclonal Antibodies Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Biologics Monoclonal Antibodies Drug Manufacturers Product Type
Table 10. China Biologics Monoclonal Antibodies Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Biologics Monoclonal Antibodies Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Biologics Monoclonal Antibodies Drug Upstream (Raw Materials)
Table 13. Global Biologics Monoclonal Antibodies Drug Typical Customers
Table 14. Biologics Monoclonal Antibodies Drug Typical Distributors
Table 15. By Type, Global Biologics Monoclonal Antibodies Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Biologics Monoclonal Antibodies Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Biologics Monoclonal Antibodies Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Biologics Monoclonal Antibodies Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2029
Table 22. Roche Company Information, Head Office, Market Area and Industry Position
Table 23. Roche Company Profile and Main Business
Table 24. Roche Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 25. Roche Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 26. Roche Recent Developments
Table 27. Amgen Company Information, Head Office, Market Area and Industry Position
Table 28. Amgen Company Profile and Main Business
Table 29. Amgen Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 30. Amgen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 31. Amgen Recent Developments
Table 32. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 33. AbbVie Company Profile and Main Business
Table 34. AbbVie Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 35. AbbVie Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 36. AbbVie Recent Developments
Table 37. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 38. Sanofi Company Profile and Main Business
Table 39. Sanofi Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 40. Sanofi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 41. Sanofi Recent Developments
Table 42. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 43. Johnson & Johnson Company Profile and Main Business
Table 44. Johnson & Johnson Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 45. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 46. Johnson & Johnson Recent Developments
Table 47. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 48. Pfizer Company Profile and Main Business
Table 49. Pfizer Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 50. Pfizer Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 51. Pfizer Recent Developments
Table 52. Eli Lilly Company Information, Head Office, Market Area and Industry Position
Table 53. Eli Lilly Company Profile and Main Business
Table 54. Eli Lilly Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 55. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 56. Eli Lilly Recent Developments
Table 57. Novartis Company Information, Head Office, Market Area and Industry Position
Table 58. Novartis Company Profile and Main Business
Table 59. Novartis Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 60. Novartis Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 61. Novartis Recent Developments
Table 62. Merck Company Information, Head Office, Market Area and Industry Position
Table 63. Merck Company Profile and Main Business
Table 64. Merck Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 65. Merck Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 66. Merck Recent Developments
Table 67. Biogen Company Information, Head Office, Market Area and Industry Position
Table 68. Biogen Company Profile and Main Business
Table 69. Biogen Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 70. Biogen Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 71. Biogen Recent Developments
Table 72. Sobi Company Information, Head Office, Market Area and Industry Position
Table 73. Sobi Company Profile and Main Business
Table 74. Sobi Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 75. Sobi Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 76. Sobi Recent Developments
Table 77. Innovent Biologics Company Information, Head Office, Market Area and Industry Position
Table 78. Innovent Biologics Company Profile and Main Business
Table 79. Innovent Biologics Biologics Monoclonal Antibodies Drug Models, Specifications and Application
Table 80. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue and Gross Margin, 2018-2023
Table 81. Innovent Biologics Recent Developments
List of Figure
Figure 1. Biologics Monoclonal Antibodies Drug Picture
Figure 2. Global Biologics Monoclonal Antibodies Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Biologics Monoclonal Antibodies Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Biologics Monoclonal Antibodies Drug Market Share of Global
Figure 5. Global Biologics Monoclonal Antibodies Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Biologics Monoclonal Antibodies Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Biologics Monoclonal Antibodies Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Biologics Monoclonal Antibodies Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Biologics Monoclonal Antibodies Drug Industry Chain
Figure 10. Infliximab
Figure 11. Rituximab
Figure 12. Trastuzumab
Figure 13. Adalimumab
Figure 14. Other
Figure 15. By Type, Global Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, US$ Million
Figure 16. By Type, Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2029
Figure 17. Cancer
Figure 18. Autoimmune Disease
Figure 19. Other
Figure 20. By Application, Global Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, US$ Million
Figure 21. By Application, Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2029
Figure 22. By Region, Global Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2029
Figure 23. North America Biologics Monoclonal Antibodies Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, North America Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
Figure 25. Europe Biologics Monoclonal Antibodies Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, Europe Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
Figure 27. Asia Pacific Biologics Monoclonal Antibodies Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country/Region, Asia Pacific Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
Figure 29. South America Biologics Monoclonal Antibodies Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. By Country, South America Biologics Monoclonal Antibodies Drug Revenue Market Share, 2018-2023
Figure 31. Middle East & Africa Biologics Monoclonal Antibodies Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 32. U.S. Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 33. By Company, U.S. Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 34. By Type, U.S. Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 35. By Application, U.S. Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 36. Europe Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 37. By Company, Europe Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 38. By Type, Europe Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 39. By Application, Europe Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 40. China Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 41. By Company, China Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 42. By Type, China Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 43. By Application, China Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 44. Japan Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 45. By Company, Japan Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 46. By Type, Japan Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 47. By Application, Japan Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 48. South Korea Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 49. By Company, South Korea Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 50. By Type, South Korea Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 51. By Application, South Korea Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 52. Southeast Asia Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 53. By Company, Southeast Asia Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 54. By Type, Southeast Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 55. By Application, Southeast Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 56. India Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 57. By Company, India Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 58. By Type, India Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 59. By Application, India Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 60. Middle East & Asia Biologics Monoclonal Antibodies Drug Revenue, 2018-2029, (US$ Million)
Figure 61. By Company, Middle East & Asia Biologics Monoclonal Antibodies Drug Market Share, 2018-2023
Figure 62. By Type, Middle East & Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 63. By Application, Middle East & Asia Biologics Monoclonal Antibodies Drug Revenue Market Share, 2022 VS 2029
Figure 64. Research Methodology
Figure 65. Breakdown of Primary Interviews
Figure 66. Bottom-up Approaches
Figure 67. Top-down Approaches
Research Methodology:
Biologics Monoclonal Antibodies Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|